A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks ALN-AS1-NT-001

Project: Other project

StatusActive
Effective start/end date8/14/1411/30/20

Funding

  • Alnylam Pharmaceuticals, Inc: $141,321.39